Open Online KYC Account
NEED HELP? 1860 500 6543

HOURS : MON TO FRI (9:00 A.M. TO 6:00 P.M)

CaptionDateDescription
Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO) 04-Nov-2019
We refer to the above captioned subject, we herewith intimate to the Exchange, that the Board of Directors has accepted the resignation of following Key Managerial Personnel. a) Resignation of Mr. Phani Srinath as Chief Financial Officer of the Company due to his personal reasons. This is for the information and records of the Exchange, please.
Allotment of Convertible warrants 24-Oct-2019
inter alia, approved the following: 1. To increase the Authorized Share Capital of the Company. 2. Issue of up to 17,05,000/- (Seventeen Lakh Five Thousand Only) Equity shares of Rs.10/- each for cash at a price of Rs. 86/- per Equity Share including premium of Rs. 76/- per share aggregating to Rs. 14,66,30,000/-. 3.Issue, on preferential basis, of upto 36,35,000 convertible warrants ('Warrant(s)') of Rs. 86/- each to Ipca Laboratories Limited, a promoter group entity. 4. Issue, on preferential basis, upto 30,00,000, 9% Redeemable Non-Convertible Non- Cumulative Preference Shares of Rs. 100/- each aggregating to Rs. 30,00,00,000/- (Rupees Thirty Crores Only) to Ipca Laboratories Limited. 5. Please note that an Extraordinary General Meeting of the Company will be held on 22nd November, 2019 to obtain shareholders approval for the above.
Allotment of Equity Shares 24-Oct-2019
inter alia, approved the following: 1. To increase the Authorized Share Capital of the Company. 2. Issue of up to 17,05,000/- (Seventeen Lakh Five Thousand Only) Equity shares of Rs.10/- each for cash at a price of Rs. 86/- per Equity Share including premium of Rs. 76/- per share aggregating to Rs. 14,66,30,000/-. 3.Issue, on preferential basis, of upto 36,35,000 convertible warrants ('Warrant(s)') of Rs. 86/- each to Ipca Laboratories Limited, a promoter group entity. 4. Issue, on preferential basis, upto 30,00,000, 9% Redeemable Non-Convertible Non- Cumulative Preference Shares of Rs. 100/- each aggregating to Rs. 30,00,00,000/- (Rupees Thirty Crores Only) to Ipca Laboratories Limited. 5. Please note that an Extraordinary General Meeting of the Company will be held on 22nd November, 2019 to obtain shareholders approval for the above.
Preferential Issue of Shares 24-Oct-2019
inter alia, approved the following: 1. To increase the Authorized Share Capital of the Company. 2. Issue of up to 17,05,000/- (Seventeen Lakh Five Thousand Only) Equity shares of Rs.10/- each for cash at a price of Rs. 86/- per Equity Share including premium of Rs. 76/- per share aggregating to Rs. 14,66,30,000/-. 3.Issue, on preferential basis, of upto 36,35,000 convertible warrants ('Warrant(s)') of Rs. 86/- each to Ipca Laboratories Limited, a promoter group entity. 4. Issue, on preferential basis, upto 30,00,000, 9% Redeemable Non-Convertible Non- Cumulative Preference Shares of Rs. 100/- each aggregating to Rs. 30,00,00,000/- (Rupees Thirty Crores Only) to Ipca Laboratories Limited. 5. Please note that an Extraordinary General Meeting of the Company will be held on 22nd November, 2019 to obtain shareholders approval for the above.
Board Meeting on Oct 23, 2019 18-Oct-2019
Krebs Biochemicals & Industries Ltd has informed BSE that the meeting of the Board of Directors of the Company will be held on October 23, 2019, inter alia, to transact the following: To consider various options to raise funds, including issue, on Preferential basis of Equity shares, Warrants convertible into equity shares and non-cumulative or cumulative redeemable Preference shares subject to approval of the shareholders at the ensuing General meeting, pursuant to applicable provisions of the Companies Act, 2013 along with applicable SEBI (LODR) Regulations, 2015, SEBI (ICDR) Regulations, 2018, as updated from time to time.
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report 27-Sep-2019
Pursuant to Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 please find enclosed herewith the details regarding the consolidated voting results and Scrutinizers report on the business transacted at the 27th Annual General Meeting held on 25th Septemeber, 2019.
Krebs Biochemicals & Industries informs about proceedings of AGM 26-Sep-2019

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, Krebs Biochemicals & Industries  has informed about submission of the summary of proceedings of the 27th Annual General Meeting of the Company held on Wednesday, 27th September, 2019 at the Registered office of the Company at kothapalli (Village), Kasimkota (Mandal), Anakapalli, Vishakapatnam (District), Andhra Pradesh - 531031. Further Jhansi Laxmi, Practicing Company Secretary is the Scrutinizer for the remote e-voting and voting process carried out at the AGM through ballot paper. The results on the resolutions shall be declared by 27th September, 2019, the declared results along with scrutinizers report shall be placed on the Company’s website at www.krebsbiochem.com and on the website of Karvy at www.karvy.com and shall also be communicated to the stock Exchange where shares of the Company are listed.

The above information is a part of company’s filings submitted to BSE.

Shareholder Meeting / Postal Ballot-Outcome of AGM 26-Sep-2019
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, please find enclosed the summary of proceedings of the 27th Annual General Meeting of the Company held on Wednesday, 27th September, 2019 at the Registred office of the Company at kothapalli (Village), Kasimkota(Mandal), Anakapalli, Vishakapatnam (District), Andhra Pradesh - 531031 Further Ms.Jhansi Laxmi, Practicing Company Secretary is the Scrutinizer for the remote e-voting and voting process carried out at the AGM through ballot paper. The results on the resolutions shall be declared by 27th September, 2019, the declared results along with scrutinizer's report shall be placed on the Company's website at www.krebsbiochem.com and on the website of Karvy at www.karvy.com and shall also be communicated to the stock Exchange where shares of the Company are listed.
Shareholder Meeting / Postal Ballot-Outcome of AGM 26-Sep-2019
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, please find enclosed the summary of proceedings of the 27th Annual General Meeting of the Company held on Wednesday, 27th September, 2019 at the Registred office of the Company at kothapalli (Village), Kasimkota(Mandal), Anakapalli, Vishakapatnam (District), Andhra Pradesh - 531031 Further Ms.Jhansi Laxmi, Practicing Company Secretary is the Scrutinizer for the remote e-voting and voting process carried out at the AGM through ballot paper. The results on the resolutions shall be declared by 27th September, 2019, the declared results along with scrutinizer's report shall be placed on the Company's website at www.krebsbiochem.com and on the website of Karvy at www.karvy.com and shall also be communicated to the stock Exchange where shares of the Company are listed.
Clarification 11-Sep-2019
With reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded, Krebs Biochemicals & Industries Ltd has submitted to BSE a copy of Clarification is enclosed.
12

Copyright 2013 Inditrade Capital Ltd. All rights reserved.

Best Viewed in Resolution 1024 * 800 and Above